Chiltern Participates in French Government Initiative as it Plans France’s Future in Pharma R&D

Chiltern International - the largest independent global Clinical Research Organisation - has been consulted by a delegation from the French Economic Ministry in an attempt by the Government to boost France's standing in the international healthcare industry. In the past year the French Government has launched several initiatives to sustain innovation, including reforming the R&D tax credit scheme and creating a new fiscal status for emerging innovative companies. All are designed to enhance France's competitive position in the international healthcare industries and make the most of the opportunities in the industry as R&D expenditure enters a healthier phase after two quiet years.

Francis Mer, the French Minister for the Economy, Finance and Industry, and Nicole Fontaine, Minister Delegate for Industry, have commissioned a fact-finding report to come up with various recommendations and as part of that process has had several consultations with British companies, including Slough-based Chiltern International.

Dr. Faiz Kermani and Mr. Yohan Vezinhet – representatives of Chiltern’s business development team, recently met the French delegation during an information-gathering trip spanning several European countries.

“Chiltern's expertise and knowledge of the sector, combined with its geographical spread in the UK, USA and mainland Europe will make our views and experiences very relevant for the French Government initiatives,” explained Dr Faiz Kermani. “The UK provides an interesting example to other countries, as it has been particularly proactive in improving the environment for biopharmaceutical R&D.”

“We found Chiltern’s views regarding the pharmaceutical industry both in France and in the rest of Europe very informative,” commented Mr. Benoit Colinot, Commercial Attaché at the French Embassy in London. “This provided us with many points to follow up concerning how France could improve its R&D environment.”

Established in London in 1982, clinical research organisation Chiltern International provides clinical operations, project management, data management, biostatistics, medical writing, quality assurance and regulatory and medical affairs services to the pharmaceutical, biotechnology and medical device industries. The company also offers clinical contract personnel services to pharmaceutical and biotechnology clients. It has ten international offices – three in the United States and seven in Europe.

ends

For further information please visit www.chiltern.com or contact:

Dr Aidan Nuttall
Chiltern International
Tel: +1 760 707 5025
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Dr Faiz Kermani
Chiltern International Limited
Tel: +44 (0)1753 512000
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Richard Gee
GBCS Public Relations Ltd.
Tel: +44 (0)115 9508399
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.